BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24801647)

  • 1. A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.
    Banelli B; Morabito A; Laurent S; Piccioli P; Dozin B; Ghio M; Ascierto PA; Monteghirfo S; Marasco A; Ottaviano V; Queirolo P; Romani M; Pistillo MP
    Hum Immunol; 2014 Aug; 75(8):730-9. PubMed ID: 24801647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CTLA-4 polymorphisms with improved overall survival in melanoma patients treated with CTLA-4 blockade: a pilot study.
    Queirolo P; Morabito A; Laurent S; Lastraioli S; Piccioli P; Ascierto PA; Gentilcore G; Serra M; Marasco A; Tornari E; Dozin B; Pistillo MP
    Cancer Invest; 2013 Jun; 31(5):336-45. PubMed ID: 23641913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.
    Torres-Carrillo N; Ontiveros-Mercado H; Torres-Carrillo NM; Parra-Rojas I; Rangel-Villalobos H; Ramírez-Dueñas MG; Gutiérrez-Ureña SR; Valle Y; Muñoz-Valle JF
    Cell Biochem Biophys; 2013; 67(3):1217-28. PubMed ID: 23703660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis.
    Balbi G; Ferrera F; Rizzi M; Piccioli P; Morabito A; Cardamone L; Ghio M; Palmisano GL; Carrara P; Pedemonte S; Sessarego M; De Angioletti M; Notaro R; Indiveri F; Pistillo MP
    Clin Exp Immunol; 2007 Jul; 149(1):40-7. PubMed ID: 17459075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
    Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
    Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.
    Queirolo P; Dozin B; Morabito A; Banelli B; Piccioli P; Fava C; Leo C; Carosio R; Laurent S; Fontana V; Ferrucci PF; Martinoli C; Cocorocchio E; Battaglia A; Ascierto PA; Capone M; Simeone E; De Galitiis F; Pagani E; Antonini Cappellini GC; Marchetti P; Guida M; Tommasi S; Mandalà M; Merelli B; Quaglino P; Fava P; Guidoboni M; Romani M; Spagnolo F; Pistillo MP
    Front Immunol; 2017; 8():386. PubMed ID: 28446908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
    Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
    Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease.
    Bicek A; Zaletel K; Gaberscek S; Pirnat E; Krhin B; Stopar TG; Hojker S
    Hum Immunol; 2009 Oct; 70(10):820-4. PubMed ID: 19559744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of CTLA-4 Single Nucleotide Polymorphisms on Toxicity of Ipilimumab-Containing Regimens in Patients With Advanced Stage Melanoma.
    de Joode K; Mora AR; van Schaik RHN; Zippelius A; van der Veldt A; Gerard CL; Läubli H; Michielin O; von Moos R; Joerger M; Levesque MP; Aeppli S; Mangana J; Mangas C; Trost N; Meyer S; Parvex SL; Mathijssen R; Metaxas Y
    J Immunother; 2024 Jun; 47(5):190-194. PubMed ID: 38318726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter region -318 C/ T and -1661 A/G CTLA-4 single nucleotide polymorphisms and type 1 diabetes in North Indians.
    Baniasadi V; Narain N; Goswami R; Das SN
    Tissue Antigens; 2006 May; 67(5):383-9. PubMed ID: 16671945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cytotoxic T-lymphocyte antigen-4 polymorphisms on acute rejection onset of cadaveric renal transplants.
    Canossi A; Aureli A; Delreno F; Iesari S; Cervelli C; Clemente K; Famulari A; Pisani F; Papola F
    Transplant Proc; 2013 Sep; 45(7):2645-9. PubMed ID: 24034013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
    Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
    Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
    Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
    Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
    Gunesacar R; Erken E; Dinkci S
    Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTLA-4 polymorphisms in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.
    Louthrenoo W; Kasitanon N; Wongthanee A; Kuwata S; Takeuchi F
    Int J Rheum Dis; 2021 Nov; 24(11):1378-1385. PubMed ID: 34533895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population.
    Bharti V; Mohanti BK; Das SN
    Hum Immunol; 2013 Mar; 74(3):348-52. PubMed ID: 23246583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No association of CTLA-4 polymorphisms with susceptibility to Behçet disease.
    Du L; Yang P; Hou S; Zhou H; Kijlstra A
    Br J Ophthalmol; 2009 Oct; 93(10):1378-81. PubMed ID: 19570770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of Association between CTLA-4 Gene Polymorphisms and Colorectal Cancers in Saudi Patients.
    Al-Harbi N; Abdulla MH; Vaali-Mohammed MA; Bin Traiki T; Alswayyed M; Al-Obeed O; Abid I; Al-Omar S; Mansour L
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.